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Dose Response for Cardiac
esynchronization Therapy?*
itchell N. Faddis, MD, PHD, FACC
t. Louis, Missouri
he consequence of synchronous, rapid activation of the left
entricle (LV) by the cardiac conduction system is an
fficient economy of energy expenditure for the work of
jection during the cardiac cycle. In the failing heart with
oncomitant conduction system disease, this economy is
isrupted, resulting in several detrimental effects to cardiac
unction. First, a significant portion of energy expended in
he cardiac cycle does not contribute to external cardiac
ork. Instead, dyssynchronous contraction of the septum
nd lateral wall allow for energy to be wasted on motion of
he partially relaxed opposite wall rather than on the work of
lood ejection (1). Second, the isovolumetric phases of the
ardiac cycle are expanded relative to systolic ejection and
iastolic filling periods, increasing “wasted time” (2). Third,
he lateral wall is subjected to an excessively high wall
train, in the case of left bundle branch block, with
esulting molecular changes that contribute to myopathic
hanges (3). The result of this pathophysiology is a worse
rognosis than heart failure uncomplicated by conduction
ystem disease (4).
See page 355
Biventricular pacing was first proposed as a way to
estore, to some degree, electrical synchronization of the
eptum and lateral wall of the LV in the setting of left
undle branch block. In the first description of a series of
atients with refractory heart failure and conduction system
isease, biventricular pacing produced substantial clinical
mprovements in most, but not all, patients (5). Subsequent
andomized clinical trials have consistently verified these
linical benefits as well as providing evidence for a modifi-
ation of the natural history of severe heart failure in
atients treated with a “state-of-the-art” heart failure med-
cal regimen manifested by a reduction in mortality and
ncidence of heart failure decompensation (6,7).
Editorials published in the Journal of the American College of Cardiology reflect the
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oston Scientific Corporation and St. Jude Medical Corporation.As a result, cardiac resynchronization therapy (CRT) has
ecome a standard of care for the treatment of patients with
V conduction delay and concomitant systolic heart failure
hat has become unresponsive to medical therapy. Despite a
onsensus on the clinical benefits of CRT, many ques-
ions remain regarding the optimal implementation of
his revolutionary therapy and a nonresponder rate in the
ange of 30%.
In this issue of the Journal, Koplan et al. (8) examine
hether the percentage of all heart beats that are biventricu-
arly paced contributes to the magnitude of the observed
eduction in the combined end point of heart failure
ospitalization and all-cause mortality resulting from CRT.
post-hoc analysis is applied to data collected from 1,812
atients derived from 2 large registries containing patients
ith CRT devices. In both registries, follow-up data were
ollected at 3-month intervals for 1 year after implant. The
uthors divided the patient cohort into quartiles based upon
ifetime percent biventricular pacing. A Kaplan-Meier sur-
ival analysis was then performed with regard to freedom
rom heart failure hospitalization and all-cause mortality.
The authors observed that, in the top 3 quartiles, in
hich patients paced more than 92% of the time, there was
44% reduction in risk of events compared with the bottom
uartile, which comprised of patients with biventricular
acing 0% to 92%. In addition, patients who received
iventricular pacing 100% of the time, or the top quartile,
ad significantly better outcomes than all of the other
uartiles. The clinical nonresponse rate was slightly lower in
he 92% pacing, 54% versus 46%, but percent biventricu-
ar pacing could not explain the entire nonresponse rate.
The authors observed several mechanisms for a reduction
n biventricular pacing. The most intuitively obvious was a
oss of LV lead function due to dislodgement or lack of
apture in 6.6% of patients in the bottom quartile. Atrial
rrhythmias also contributed significantly to a reduction in
iventricular pacing percentage, presumably resulting from
eriods of intrinsic conduction above the programmed lower
ate limit. A related characteristic observed in the lowest
uartile was a relative underutilization of the ventricular rate
egulation feature, whereby biventricular pacing in the
resence of atrial fibrillation is increased by dynamic adjust-
ent of the lower rate limit. A third mechanism that may
ave contributed to a reduction in biventricular pacing
ercentage was intrinsic conduction “beating” the pro-
rammed atrioventricular (AV) delay. This possibility is
upported by a significantly longer programmed AV delay in
he bottom quartile.
Is there a dose-response for CRT? You cannot say from
hese data. The intention of treatment in all patients was to
chieve 100% biventricular pacing. Interestingly, this was
nly realized in the top quartile of patients, although 75%
ad more than 92% biventricular pacing. The lowest quar-
ile appears to be inhomogeneous in regard to percent
iventricular pacing. A significant number had no biven-
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Dose Response for CRT January 27, 2009:361–2ricular pacing because the LV lead had been turned off. In
he remainder, LV pacing was active most of the time. The
arked reduction in benefit in this quartile suggests an
ssentially all or none effect of biventricular pacing. In
atients with significant biventricular pacing percentages in
he lowest quartile, it is possible that insufficient LV
re-excitation occurred to allow for significant resynchroni-
ation of the left ventricle. Additional information that
ould have shed further light on this possibility is measure-
ent of the intracardiac atrial sense or pace to LV sense
nterval. Other mechanisms of ineffective CRT such as
nappropriate lead location may also have been operative but
his seems unlikely to be concentrated in the lowest quartile.
What about atrial fibrillation? Although, atrial fibrillation
as more likely in the lowest quartile, other information
uggests that heart failure patients with atrial fibrillation can
espond to CRT to a similar degree as patients in normal
inus rhythm (9). The added challenge to provide clinical
enefits of CRT in atrial fibrillation patients is to ensure
iventricular pacing through adequate blockade of native
onduction through the AV node. When this is not possible
harmacologically, catheter ablation of the AV node has
een shown to be useful to enhance the efficacy of CRT
10). The ventricular rate regulation feature, which was not
sed as much in the lowest quartile patients of this study,
rovides a means of dynamic adjustment of the lower rate
imit as an additional means to ensure adequate biventricular
acing.
In summary, what should the target be for biventricular
acing percentage? This analysis suggests that benefits of
RT require pacing percentages as close to 100% as
ossible. Beyond simple pacing percentages, however, there
ppears to be additional opportunities to improve the
linical response to CRT that continues to be plagued by a
ignificant nonresponse rate. Whether advancement of LV
re-excitation through V-V interval adjustment may in-
rease the clinical response to CRT was not tested in this
tudy. Additional methods of visualizing the adequacy of
V resynchronization and guiding atrioventricular delay
nd V-V delay programming through tissue Doppler echo-
ardiography (11) or electrocardiographic imaging (12) may
rovide the opportunity to further improve CRT delivery.
uidance of the LV lead implantation site to areas of the
V predicted by pre-operative imaging may also provide Kn additional tool to improve the delivery of adequate
esynchronization.
eprint requests and correspondence: Dr. Mitchell N. Faddis,
ashington University School of Medicine, 660 South Euclid
venue, Campus Box 8086, St. Louis, Missouri 63110. E-mail:
faddis@wustl.edu.
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